Sex Differences in the Level of Homocysteine in Alzheimer’s Disease and Parkinson’s Disease Patients: A Meta-Analysis
Although recent studies suggest homocysteine (Hcy) is an independent risk factor for neurodegenerative disorders, little is known about sex differences in the levels of Hcy. In this study, we conducted a comparative meta-analysis to investigate sex differences in the levels of Hcy in both Alzheimer’...
Main Authors: | V. Phu Nguyen, Andrila E. Collins, Jordan P. Hickey, Julia A. Pfeifer, Bettina E. Kalisch |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-01-01
|
Series: | Brain Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-3425/13/1/153 |
Similar Items
-
One-Carbon Metabolism in Alzheimer’s Disease and Parkinson’s Disease Brain Tissue
by: Karel Kalecký, et al.
Published: (2022-01-01) -
Blood and CSF Homocysteine Levels in Alzheimer’s Disease: A Meta-Analysis and Meta-Regression of Case–Control Studies
by: Zhang L, et al.
Published: (2022-10-01) -
Increased serum homocysteine in first episode and drug-naïve individuals with schizophrenia: sex differences and correlations with clinical symptoms
by: Xu Yang, et al.
Published: (2022-12-01) -
Hyperhomocysteinemia in Parkinson’s disease – new variant of complications of ongoing therapy or specific biochemical marker of the disease?
by: I. V. Litvinenko, et al.
Published: (2017-02-01) -
Naturally Occurring Antioxidant Therapy in Alzheimer’s Disease
by: Andrila E. Collins, et al.
Published: (2022-01-01)